Khaldoon Alaswad, M.D., right, director, cardiac catheterization lab, during a complex CTO procedure at Henry Ford Hospital.

Henry Ford Hospital thought leaders regularly speak at the cardiology conferences about new research and technology innovations. So, it was an honor when DAIC was invited to conduct a site visit at Henry Ford recently to tour its facilities, sit in on procedures and conduct numerous video interviews to better understand the workings of the institution. 

I recently had the opportunity to conduct an onsite visit to the University of Colorado Hospital Heart and Vascular Center at the Anschutz Medical Campus in Aurora, Colo., which is part of UCHealth.

June 10, 2026 — Siemens Healthineers has entered into a project agreement with the Advanced Research Projects Agency for Health (ARPA-H) to undertake research focused on enhancing the cyber resilience of medical devices. ARPA-H's Universal Patching and Remediation for Autonomous Defense (UPGRADE) program aims to create new tools to help hospitals’ information technology teams better detect and remediate cyber-threats2.

June 9, 2026.— Pentixapharm Holding AG has announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for its lead CXCR4-targeted diagnostic program in treatment resistant hypertension with underlying Primary Aldosteronism.

June 8, 2026 – Embolization, Inc. will present its novel embolization coil, using proprietary shape-memory biocompatible polymers to treat peripheral vasculature at the Vascular Annual Meeting, in Boston, Massachusetts.

June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform update that introduces the MyoVista Insights AI-ECG Algorithm Marketplace. The Marketplace enables third-party algorithm results to be integrated into the MyoVista Insights platform, beginning with an FDA-cleared AI-ECG model from Bunkerhill Health.

May 11, 2026 — In May, Robocath announced the completion of patient enrollment in the FIH (First-In-Human) clinical study evaluating its next-generation robotic system for percutaneous coronary interventions (PCI).

March 25, 2026 — At ACC.26, GE HealthCare will showcase some of its latest solutions that support clinicians across the cardiology care pathway — from diagnosis to treatment to procedural guidance and monitoring. Its latest cardiology innovations, featuring advancements within diagnostic cardiology, CT, image guiding solutions, ultrasound, cloud and software solutions are helping clinicians deliver critical precision care throughout the patient journey.

June 2, 2026 — Clarius Mobile Health has announced the availability of its new Ejection Fraction (EF) AI, which has been cleared for use by the United States Federal Department of Food and Drug Administration (FDA). This intelligent cardiac assessment tool is integrated directly into the Clarius Ultrasound App to provide clinicians with an automated, objective measurement of left ventricular function — the percentage of blood the heart pumps out with each beat.

June 3, 2026 — Medtronic has announced strategic investments in two privately held companies focused on the development of intracardiac echocardiography (ICE) catheter technologies. ICE catheters provide real-time, high-resolution imaging of the heart during electrophysiology (EP) procedures for cardiac arrhythmias such as atrial fibrillation (Afib). Medtronic intends to integrate ICE into the Affera mapping and ablation system to continue building on the differentiated value proposition of the Affera ecosystem.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now